TP53 and neoplasm: Several thousands malignant tumor cell lines with different TP53 mutations were analyzed, subjected to substances activating p53: nutlin-3 (inhibitor of MDM2 and p53 binding) or etoposide (topoisomerase II inhibitor, causing DNA damage).